The world is full of mysteries, not least of which is the system whereby issues of the Bio-Science Law Review are numbered. We've just hit January 2005, but the IPKat's letterbox has just admitted "Volume 6 Issue 5 2003/2004" of that excellent publication. This issue contains, amon other things, the following features:
* David J. Faye (Borden Ladner Gervais, Toronto) considers the legal position regarding the exploitation of research tool patents in plant biotechnology;The BioSLR is published at intervals of approximately two months by Lawtext Publishing, who also publish the Information Technology Law Reports.
* Olivier Lemaire (NautaDutilh, Brussels) writes on the protection accorded to regulatory data in the light of the ECJ ruling in C-106/01 Novartis v SangStat.
Do you want to reuse the IPKat content? Please refer to our
Policies section.
If you have any queries or requests for permission, please get in touch with the IPKat team.
Comments
Post a Comment
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html